Firebrick Pharma (ASX:FRE) decided not to proceed with a previously proposed share placement, following the company's request to be placed in a trading halt pending the announcement of the placement, according to a June 6 filing with the Australian bourse.
On June 5, the company said the trading halt will remain in effect until the earlier of the start of normal trading on Tuesday or the release of the disclosure.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.